Miller, Andrew H. http://orcid.org/0000-0001-8260-7997
Raison, Charles L. http://orcid.org/0000-0001-6687-0066
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R21 MH121891, R44 MH125480, R01 MH112076, R01 MH128872)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR002378)
Article History
Received: 23 July 2022
Revised: 26 October 2022
Accepted: 11 November 2022
First Online: 2 December 2022
Competing interests
: AHM is a paid consultant for Cerevel Therapeutics, and CLR is a paid consultant for Novartis, Alfasigma, Usona Institute and Emory Healthcare.